296 related articles for article (PubMed ID: 12482341)
81. Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.
Bai J; Xue Y; Ye L; Yao J; Zhou C; Shao Z; Qian L; Yang R; Li H; Zhang H; Zheng Y
Int J Hematol; 2008 Dec; 88(5):530-535. PubMed ID: 19002391
[TBL] [Abstract][Full Text] [Related]
82. Endogenous erythroid colony formation by peripheral blood mononuclear cells from patients with myelofibrosis and polycythemia vera.
Lutton JD; Levere RD
Acta Haematol; 1979; 62(2):94-9. PubMed ID: 119408
[TBL] [Abstract][Full Text] [Related]
83. Long-term outcomes of polycythemia vera patients treated with pipobroman as initial therapy.
Kiladjian JJ; Gardin C; Renoux M; Bruno F; Bernard JF
Hematol J; 2003; 4(3):198-207. PubMed ID: 12764352
[TBL] [Abstract][Full Text] [Related]
84. [Erythrocyte volume and 2,3-DPG level. A study on a primary polycythemia model].
Tassiopoulos T; Fessas P; Pangalis G; Andreopoulos A; Loukopoulos D
Nouv Rev Fr Hematol (1978); 1983; 25(4):263-6. PubMed ID: 6622251
[TBL] [Abstract][Full Text] [Related]
85. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
[TBL] [Abstract][Full Text] [Related]
86. The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.
Jakovic L; Gotic M; Gisslinger H; Soldatovic I; Sefer D; Tirnanic M; Lekovic D; Jovanovic MP; Schalling M; Gisslinger B; Beham-Schmid C; Simonitsch-Klupp I; Thiele J
Ann Hematol; 2018 Sep; 97(9):1581-1590. PubMed ID: 29717365
[TBL] [Abstract][Full Text] [Related]
87. Clinical and laboratory assessment and therapeutic problems in longstanding polycythaemia vera.
Rain JD
Nouv Rev Fr Hematol (1978); 1994 Apr; 36(2):197-203. PubMed ID: 8036142
[TBL] [Abstract][Full Text] [Related]
88. Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled Disease.
Geyer H; Scherber R; Kosiorek H; Dueck AC; Kiladjian JJ; Xiao Z; Slot S; Zweegman S; Sackmann F; Fuentes AK; Hernández-Maraver D; Döhner K; Harrison CN; Radia D; Muxi P; Besses C; Cervantes F; Johansson PL; Andreasson B; Rambaldi A; Barbui T; Bonatz K; Reiter A; Boyer F; Etienne G; Ianotto JC; Ranta D; Roy L; Cahn JY; Maldonado N; Barosi G; Ferrari ML; Gale RP; Birgegard G; Xu Z; Zhang Y; Sun X; Xu J; Zhang P; te Boekhorst PA; Commandeur S; Schouten H; Pahl HL; Griesshammer M; Stegelmann F; Lehmann T; Senyak Z; Vannucchi AM; Passamonti F; Samuelsson J; Mesa RA
J Clin Oncol; 2016 Jan; 34(2):151-9. PubMed ID: 26598745
[TBL] [Abstract][Full Text] [Related]
89. Polycythemia vera and idiopathic erythrocytosis: comparison of clinical and laboratory parameters.
Usman M; Bilwani F; Kakepoto GN; Adil SN; Sajid R; Khurshid M
J Pak Med Assoc; 2004 May; 54(5):249-51. PubMed ID: 15270182
[TBL] [Abstract][Full Text] [Related]
90. [Clinical picture and pathogenesis of osteomyelosclerosis].
Müller D
Dtsch Med Wochenschr; 1970 Mar; 95(12):643-8. PubMed ID: 4915274
[No Abstract] [Full Text] [Related]
91. Analysis on 71 patients with polycythemia vera.
Xin CH; Xu JQ; Sui JR; Wang XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):667-70. PubMed ID: 22739179
[TBL] [Abstract][Full Text] [Related]
92. Polycythemia: a disease of all ages.
Libre EP
Geriatrics; 1974 Oct; 29(10):124-34. PubMed ID: 4415114
[No Abstract] [Full Text] [Related]
93. [Neurologic manifestations of polycythemia vera. Analysis of 24 cases and review of the literature].
Corredoira Sánchez JC; González López M; Cortés Laiño JA; Gomara García S; Pérez Alvarez R; Casariego Vales B; López Alvarez MJ; García Rodríguez JF
An Med Interna; 1990 Feb; 7(2):67-70. PubMed ID: 2103237
[TBL] [Abstract][Full Text] [Related]
94. Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay.
Shih LY; Lee CT
Blood; 1994 Feb; 83(3):744-8. PubMed ID: 8298136
[TBL] [Abstract][Full Text] [Related]
95. Complications and conversions in myeloproliferative disorders: an analysis of 356 cases.
Wang Y; Zuo A; Liu Y; Liu B; Hao C; Wang L; Zhou X; Qian L
Zhonghua Xue Ye Xue Za Zhi; 2002 Jun; 23(6):314-7. PubMed ID: 12411064
[TBL] [Abstract][Full Text] [Related]
96. [Microangiopathic hemolytic anemia in patients with diseases of the hematopoietic and lymphatic systems].
Paprocka E; Dwilewicz-Trojaczek J; Wieczorek J; Kuratowska Z
Pol Tyg Lek; 1989 Apr; 44(14):323-6. PubMed ID: 2622805
[TBL] [Abstract][Full Text] [Related]
97. Fetal hemoglobin in polycythemia vera: cellular distribution in 50 unselected patients.
Hoffman R; Papayannopoulou T; Landaw S; Wasserman LR; DeMarsh QB; Chen P; Stamatoyannopoulos G
Blood; 1979 Jun; 53(6):1148-55. PubMed ID: 444654
[TBL] [Abstract][Full Text] [Related]
98. Multiple thromboses in polycythemia vera.
Mork JN; Barlow JF
Minn Med; 1978 Apr; 61(4):209-10. PubMed ID: 642903
[No Abstract] [Full Text] [Related]
99. [Study of splenic erythropoiesis with radioisotopes in polycythemia vera complicated by myelosclerosis. (Study of 5 cases)].
Vilcu A; Xenakis A; Hossu T; Câmpeanu L; Marcu I; Teitel P
Med Interna (Bucur); 1973 Sep; 25(9):1117-26. PubMed ID: 4792532
[No Abstract] [Full Text] [Related]
100. Hematocrit in thrombotic stroke at Ramathibodi Hospital.
Jootar S; Withoonpanich R; Niramarnsakul S
J Med Assoc Thai; 1989 Feb; 72(2):97-100. PubMed ID: 2738492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
